Related Experiment Video

Updated: Jan 15, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.1K

Striking elevation of alpha-fetoprotein during acute transient myopathy following Yttrium-90 transarterial

Arjan Deol1, Jonathan Lindquist2, Katherine Marchak2

  • 1University of Colorado School of Medicine, Aurora CO, USA.

Journal of Hepatology
|October 11, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.9K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K

Related Experiment Videos

Last Updated: Jan 15, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.1K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.9K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K

Articles linked to this work by shared authors, journal, and citation graph.

Knee OA Pathophysiologic Rationale: Synovial Neovascularization and Neurogenic Inflammation.

Seminars in interventional radiology·2026

Thermal Ablation of Hypervascular Liver Tumors After Selective Intra-Arterial Lipiodol Injection (SIALI): A Technical Narrative Review of Technique, Institutional Variations, and Published Evidence.

Cancers·2026

Strategies Associated With High Inferior Vena Cava Filter Retrieval: A Positive Deviance Study.

Journal of the American College of Radiology : JACR·2026

Lipiodol in embolization therapy: Evolution from a diagnostic to a therapeutic agent.

Clinical imaging·2026

Vacuum-assisted thrombectomy for intracardiac and intravascular thrombi: A single-center experience.

JTCVS structural and endovascular·2026

Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Blood·2026

Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis.

Journal of hepatology·2026

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

Journal of hepatology·2026

Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

Journal of hepatology·2026

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

Journal of hepatology·2026

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

Journal of hepatology·2026

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Journal of hepatology·2026

Hybrid exosome-liposome nanovesicles as delivery platforms for therapeutic applications: merging the best of both worlds.

Theranostics·2026

A nanoengineered MSC therapeutic for synergistic therapy of lupus nephritis via cfDNA clearance and targeted immunomodulation.

Theranostics·2026

An inducible human LDLR transgenic mouse model for enhanced lentiviral gene delivery to murine immune cells.

Frontiers in immunology·2026

Transcranial ultrasound stimulation of the right globus pallidus interna in schizophrenia: A randomized, sham-controlled pilot study.

NPJ acoustics·2026

Case report: Clinical utility and limitations of high-frequency ultrasound for monitoring sonidegib response in nodular basal cell carcinoma: a three-case series.

Frontiers in oncology·2026

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

Haematologica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us